|
Persistent Identifier
|
doi:10.23708/0FAK1C |
|
Publication Date
|
2026-10-08 |
|
Title
| Reverse vaccinology pipeline for epitope-based vaccine development and its application in human leishmaniases |
|
Subtitle
| Experimental data generated through immunological analyses (ELISpot Data and Multiplex cytokine-bead assay (CBA) |
|
Alternative Title
| Reverse vaccinology pipeline and pan‑leishmania epitope vaccines |
|
Author
| Pissarra, Joana (Institut de Recherche pour le Développement) - ORCID: 0000-0002-0506-8042
Petitdidier, Elodie (Institut de Recherche pour le Développement) - ORCID: 0000-0002-8554-8424
Pagniez, Julie (Institut de Recherche pour le Développement) - ORCID: 0000-0002-2151-3572
Meddeb-Garnaoui, Amel (Institut Pasteur de Tunis) - ORCID: 0000-0002-1581-2779
Lemesre, Jean-Loup (Institut de Recherche pour le Développement) - ORCID: 0000-0002-7406-8820
Bras-Gonçalves, Rachel (Institut de recherche pour le développement) - ORCID: 0000-0002-3089-4530 |
|
Point of Contact
|
Use email button above to contact.
Pissarra, Joana (IRD - Institut de Recherche pour le Développement)
Pagniez, Julie (Institut de Recherche pour le Développement)
Bras-Gonçalves, Rachel (Institut de recherche pour le développement) |
|
Description
| A computational–experimental pipeline was used to screen the secretomes of six human pathogenic Leishmania species and identify pan-specific T-cell epitopes as potential candidates for a pan-leishmaniasis vaccine. Computationally predicted antigens were experimentally validated using PBMCs from naturally exposed healed human donors. IFN-γ ELISpot and multiplex cytokine bead assays (CBA) revealed positive immune recall responses against several peptide pools, confirming their predicted immunogenicity in vitro. Experimental immunological data were generated from samples collected from healed donors (TUN1,TUN3,TUN4,TUN5,TUN6,TUN7,TUN8,TUN9) previously cured of cutaneous leishmaniasis (CL) caused by L. major in Gafsa, central Tunisia, and from healthy individuals (TUNN1, TUNN2, TUNN3, TUNN4, TUNN5, TUNN6, TUNN7, TUNN8,TUNN9, TUNN10) with no history of leishmaniasis recruited from low- or non-endemic areas (Tunis). (2026-09-14) |
|
Subject
| Medicine, Health and Life Sciences |
|
Keyword
| Leishmania http://purl.obolibrary.org/obo/NCBITaxon_5658 (NCBI Taxonomy (NCBITaxon)) http://purl.obolibrary.org/obo/ncbitaxon.owl
peripheral blood mononuclear cell http://purl.obolibrary.org/obo/CL_2000001 (Cell Ontology (CL)) http://purl.obolibrary.org/obo/cl.owl
Epitopes, T-Lymphocyte http://id.nlm.nih.gov/mesh/D018984 (Medical Subject Headings (MeSH)) https://id.nlm.nih.gov/mesh/
T-helper 1 type immune response http://purl.obolibrary.org/obo/GO_0042088 (Gene Ontology (GO)) http://purl.obolibrary.org/obo/go.owl
Cytokine http://purl.obolibrary.org/obo/NCIT_C20464 (NCI Thesaurus (NCIt)) http://purl.obolibrary.org/obo/ncit.owl
Secretome http://id.nlm.nih.gov/mesh/D000089282 (Medical Subject Headings (MeSH)) https://id.nlm.nih.gov/mesh/
Reverse Vaccinology http://id.nlm.nih.gov/mesh/D000099138 (Medical Subject Headings (MeSH)) https://id.nlm.nih.gov/mesh/
t cell epitope prediction http://purl.obolibrary.org/obo/OBI_0200060 (Ontology for Biomedical Investigations (OBI)) http://purl.obolibrary.org/obo/obi.owl
MHC protein complex binding http://purl.obolibrary.org/obo/GO_0023023 (Gene Ontology (GO)) http://purl.obolibrary.org/obo/go.owl
peptide antigen binding http://purl.obolibrary.org/obo/GO_0042605 (Gene Ontology (GO)) http://purl.obolibrary.org/obo/go.owl
peptide vaccine http://purl.obolibrary.org/obo/VO_0000577 (Vaccine Ontology (VO)) http://purl.obolibrary.org/obo/vo.owl |
|
Scientific Theme
| Health: generalities (NumeriSud) https://uri.ird.fr/so/kos/tnu/050 |
|
Depositor
| PAGNIEZ, Julie |
|
Deposit Date
| 2026-09-14 |
|
Data Type
| Experimental data; Aggregate data |
|
Series
| ELISpot Dataset: IFN-γ ELISpot PBMCs were cultured for 16–20 h with positive controls (PHA, L.infantum TSLA, LiESAP mL (Leishmania infantum excreted-secreted antigens, GMP-produced CaniLeish® without adjuvant)), peptide pools (ALL_I, ALL_I+II, ALL_II, I_Pool1 at I_Pool7, I_PoolA at I_PoolG, II_Pool1 at II_Pool5, II_PoolA at II_PoolE), or culture medium as a negative control (NS), in triplicate. IFN-γ secretion was detected using a biotinylated anti-human IFN-γ mAb (7-B6-1; Mabtech), and spots were quantified with a CTL ImmunoSpot reader (CTL Analyzers, Shaker Heights, OH, USA).
CBA dataset: Multiplex cytokine-bead assay (CBA) Cytokine production was assessed using the LEGENDplex™ Human CD8/NK Panel (V02) (BioLegend). PBMC culture supernatants were analyzed for GM-CSF, Granzyme B, IFN-γ, IL-2, IL-4, IL-6, IL-10, IL-17A, IL-21, MCP-1 (CCL2), Perforin, and TNF-α. Samples were acquired on an Attune Acoustic Focusing Cytometer (Thermo Fisher Scientific), and cytokine concentrations were calculated from fluorescence signals using standard curves generated from the provided cytokine standards. |
|
Software
| LEGENDplex, Version: v8.0 |